help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bouros, D.
Right arrow Articles by du Bois, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bouros, D.
Right arrow Articles by du Bois, R. M.
American Journal of Respiratory and Critical Care Medicine Vol 165. pp. 1581-1586, (2002)
© 2002 American Thoracic Society

Original Article

Histopathologic Subsets of Fibrosing Alveolitis in Patients with Systemic Sclerosis and Their Relationship to Outcome

Demosthenes Bouros, Athol U. Wells, Andrew G. Nicholson, Thomas V. Colby, Vlasis Polychronopoulos, Panos Pantelidis, Patricia L. Haslam, Dimitris A. Vassilakis, Carol M. Black and Roland M. du Bois

Royal Brompton Hospital; Royal Free Hospital, London, United Kingdom; and Mayo Clinic, Scottsdale, Arizona

Correspondence and requests for reprints should be addressed to Athol Wells, M.D., Interstitial Lung Disease Unit, National Heart and Lung Institute, at Imperial College, Emmanuel Kaye Bld, 1 Manresa Rd., London SW3 6LR, UK. E-mail: a.wells{at}rbh.nthames.nhs.uk

Fibrosing alveolitis associated with systemic sclerosis (FASSc) has a better prognosis than idiopathic pulmonary fibrosis. In view of recent reports that idiopathic nonspecific interstitial pneumonia (NSIP) has a better prognosis than idiopathic usual interstitial pneumonia (UIP), we classified histologic appearances of surgical lung biopsies performed in 80 patients with FASSc. NSIP (n = 62, 77.5%), subcategorized as cellular NSIP (n = 15) and fibrotic NSIP (n = 47) was much more prevalent than UIP (n = 6), end-stage lung disease (ESL, n = 6), or other patterns (n = 6). There were 25 deaths (NSIP 16/62, 26%; UIP/ESL 6/12, 50%). Five-year survival differed little between NSIP (91%) and UIP/ESL (82%); mortality was associated with lower initial carbon monoxide diffusing capacity (DLCO) and FVC levels (p = 0.004 and p = 0.007, respectively). Survival and serial FVC and DLCO trends did not differ between cellular and fibrotic NSIP. Increased mortality in NSIP was associated with lower initial DLCO levels (p = 0.04), higher BAL eosinophil levels (p = 0.03), and deterioration in DLCO levels during the next 3 years (p < 0.005). We conclude that NSIP is the histopathologic pattern in most patients with FASSc. However, outcome is linked more strongly to disease severity at presentation and serial DLCO trends than to histopathologic findings.

Key Words: fibrosing alveolitis • systemic sclerosis • nonspecific interstitial pneumonia • histopathology • survival




This article has been cited by other articles:


Home page
 Am. J. Respir. Crit. Care Med.Home page
K. M. Antoniou, D. M. Hansell, M. B. Rubens, K. Marten, S. R. Desai, N. M. Siafakas, A. G. Nicholson, R. M. du Bois, and A. U. Wells
Idiopathic Pulmonary Fibrosis: Outcome in Relation to Smoking Status
Am. J. Respir. Crit. Care Med., January 15, 2008; 177(2): 190 - 194.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
G. E. Tzelepis, S. P. Toya, and H. M. Moutsopoulos
Occult connective tissue diseases mimicking idiopathic interstitial pneumonias
Eur. Respir. J., January 1, 2008; 31(1): 11 - 20.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
C. Strange, M. B. Bolster, M. D. Roth, R. M. Silver, A. Theodore, J. Goldin, P. Clements, J. Chung, R. M. Elashoff, R. Suh, et al.
Bronchoalveolar Lavage and Response to Cyclophosphamide in Scleroderma Interstitial Lung Disease
Am. J. Respir. Crit. Care Med., January 1, 2008; 177(1): 91 - 98.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
R. du Bois and T. E King Jr
Challenges in pulmonary fibrosis {middle dot} 5: The NSIP/UIP debate
Thorax, November 1, 2007; 62(11): 1008 - 1012.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
D. S. Kim and S. Nagai
Idiopathic Nonspecific Interstitial Pneumonia: An Unrecognized Autoimmune Disease?
Am. J. Respir. Crit. Care Med., October 1, 2007; 176(7): 632 - 633.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
B. W. Kinder, H. R. Collard, L. Koth, D. I. Daikh, P. J. Wolters, B. Elicker, K. D. Jones, and T. E. King Jr.
Idiopathic Nonspecific Interstitial Pneumonia: Lung Manifestation of Undifferentiated Connective Tissue Disease?
Am. J. Respir. Crit. Care Med., October 1, 2007; 176(7): 691 - 697.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
A. BEREZNE, D. VALEYRE, B. RANQUE, L. GUILLEVIN, and L. MOUTHON
Interstitial Lung Disease Associated with Systemic Sclerosis: What Is the Evidence for Efficacy of Cyclophosphamide?
Ann. N.Y. Acad. Sci., September 1, 2007; 1110(1): 271 - 284.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
R. M. du Bois
State of the Art. Mechanisms of Scleroderma-induced Lung Disease
Proceedings of the ATS, August 15, 2007; 4(5): 434 - 438.
[Abstract] [Full Text] [PDF]

Home page
 QJMHome page
H. Penn, A.J. Howie, E.J. Kingdon, C.C. Bunn, R.J. Stratton, C.M. Black, A. Burns, and C.P. Denton
Scleroderma renal crisis: patient characteristics and long-term outcomes
QJM, August 1, 2007; 100(8): 485 - 494.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
K. P. Tiev, J. Cabane, F. Aubourg, A. Kettaneh, M. Ziani, L. Mouthon, S. Duong-Quy, I. Fajac, L. Guillevin, and A. T. Dinh-Xuan
Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide
Eur. Respir. J., July 1, 2007; 30(1): 26 - 30.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. H. Park, D. S. Kim, I-N. Park, S. J. Jang, M. Kitaichi, A. G. Nicholson, and T. V. Colby
Prognosis of Fibrotic Interstitial Pneumonia: Idiopathic versus Collagen Vascular Disease-related Subtypes
Am. J. Respir. Crit. Care Med., April 1, 2007; 175(7): 705 - 711.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A. Scheja, K. Larsen, L. Todorova, E. Tufvesson, M. Wildt, A. Akesson, L. Hansson, S. Ellis, and G. Westergren Thorsson
BALF-derived fibroblasts differ from biopsy-derived fibroblasts in systemic sclerosis
Eur. Respir. J., March 1, 2007; 29(3): 446 - 452.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
M H Buch, C P Denton, D E Furst, L Guillevin, L J Rubin, A U Wells, M Matucci-Cerinic, G Riemekasten, P Emery, H Chadha-Boreham, et al.
Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlations of the 6-min walk test
Ann Rheum Dis, February 1, 2007; 66(2): 169 - 173.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
V. Cottin
Interstitial lung disease: are we missing formes frustes of connective tissue disease?
Eur. Respir. J., November 1, 2006; 28(5): 893 - 896.
[Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
S. N. C. Liossis, A. Bounas, and A. P. Andonopoulos
Mycophenolate mofetil as first-line treatment improves clinically evident early scleroderma lung disease
Rheumatology, August 1, 2006; 45(8): 1005 - 1008.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
F. J. Martinez and W. J. McCune
Cyclophosphamide for scleroderma lung disease.
N. Engl. J. Med., June 22, 2006; 354(25): 2707 - 2709.
[Full Text] [PDF]

Home page
 GutHome page
C Rigamonti, L M Shand, M Feudjo, C C Bunn, C M Black, C P Denton, and A K Burroughs
Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis
Gut, March 1, 2006; 55(3): 388 - 394.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
F. J. Martinez
Idiopathic Interstitial Pneumonias: Usual Interstitial Pneumonia versus Nonspecific Interstitial Pneumonia.
Proceedings of the ATS, January 1, 2006; 3(1): 81 - 95.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
U. B.S. Prakash
Uncommon Causes of Cough: ACCP Evidence-Based Clinical Practice Guidelines
Chest, January 1, 2006; 129(1_suppl): 206S - 219S.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
P. W. Noble, L. Tanoue, and R. Homer
Case Study Review
Chest, November 1, 2005; 128(5_suppl_1): 540S - 546S.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
T. E. King Jr.
Clinical Advances in the Diagnosis and Therapy of the Interstitial Lung Diseases
Am. J. Respir. Crit. Care Med., August 1, 2005; 172(3): 268 - 279.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
H.-K. Lee, D. S. Kim, B. Yoo, J. B. Seo, J.-Y. Rho, T. V. Colby, and M. Kitaichi
Histopathologic Pattern and Clinical Features of Rheumatoid Arthritis-Associated Interstitial Lung Disease
Chest, June 1, 2005; 127(6): 2019 - 2027.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
J. C. Grutters and R. M. du Bois
Genetics of fibrosing lung diseases
Eur. Respir. J., May 1, 2005; 25(5): 915 - 927.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
I. Ito, S. Nagai, M. Kitaichi, A. G. Nicholson, T. Johkoh, S. Noma, D. S. Kim, T. Handa, T. Izumi, and M. Mishima
Pulmonary Manifestations of Primary Sjogren's Syndrome: A Clinical, Radiologic, and Pathologic Study
Am. J. Respir. Crit. Care Med., March 15, 2005; 171(6): 632 - 638.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
S. R. Desai, S. Veeraraghavan, D. M. Hansell, A. Nikolakopolou, N. S. L. Goh, A. G. Nicholson, T. V. Colby, C. P. Denton, C. M. Black, R. M. du Bois, et al.
CT Features of Lung Disease in Patients with Systemic Sclerosis: Comparison with Idiopathic Pulmonary Fibrosis and Nonspecific Interstitial Pneumonia
Radiology, August 1, 2004; 232(2): 560 - 567.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
F Meloni, R Caporali, A Marone Bianco, E Paschetto, M Morosini, A M Fietta, F Bobbio-Pallavicini, E Pozzi, and C Montecucco
Cytokine profile of bronchoalveolar lavage in systemic sclerosis with interstitial lung disease: comparison with usual interstitial pneumonia
Ann Rheum Dis, July 1, 2004; 63(7): 892 - 894.
[Full Text]

Home page
 ThoraxHome page
A G Nicholson, B J Addis, H Bharucha, C A Clelland, B Corrin, A R Gibbs, P S Hasleton, K M Kerr, N B N Ibrahim, S Stewart, et al.
Inter-observer variation between pathologists in diffuse parenchymal lung disease
Thorax, June 1, 2004; 59(6): 500 - 505.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A. Prasse, K-M. Muller, C. Kurz, H. Hamm, and J.C. Virchow Jr
Does interferon-{gamma} improve pulmonary function in idiopathic pulmonary fibrosis?
Eur. Respir. J., December 1, 2003; 22(6): 906 - 911.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. W. Noble and D. G. Morris
Time Will Tell: Predicting Survival in Idiopathic Interstitial Pneumonia
Am. J. Respir. Crit. Care Med., September 1, 2003; 168(5): 510 - 511.
[Full Text] [PDF]

Home page
 ChestHome page
R. M. Ross
The Clinical Diagnosis of Asbestosis in This Century Requires More Than a Chest Radiograph
Chest, September 1, 2003; 124(3): 1120 - 1128.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. I. Latsi, R. M. du Bois, A. G. Nicholson, T. V. Colby, D. Bisirtzoglou, A. Nikolakopoulou, S. Veeraraghavan, D. M. Hansell, and A. U. Wells
Fibrotic Idiopathic Interstitial Pneumonia: The Prognostic Value of Longitudinal Functional Trends
Am. J. Respir. Crit. Care Med., September 1, 2003; 168(5): 531 - 537.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
V. Cottin, F. Thivolet-Bejui, M. Reynaud-Gaubert, J. Cadranel, P. Delaval, P-J. Ternamian, J-F. Cordier, and and the Groupe d'Etudes et de Recherche sur les Ma
Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis
Eur. Respir. J., August 1, 2003; 22(2): 245 - 250.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
K. R. Flaherty, T. V. Colby, W. D. Travis, G. B. Toews, J. Mumford, S. Murray, V. J. Thannickal, E. A. Kazerooni, B. H. Gross, J. P. Lynch III, et al.
Fibroblastic Foci in Usual Interstitial Pneumonia: Idiopathic versus Collagen Vascular Disease
Am. J. Respir. Crit. Care Med., May 15, 2003; 167(10): 1410 - 1415.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
V. Saravanan and C. A. Kelly
Survival in fibrosing alveolitis associated with rheumatoid arthritis is better than cryptogenic fibrosing alveolitis
Rheumatology, April 1, 2003; 42(4): 603 - 604.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Tuberculosis, Lung Infections, Interstitial Lung Disease, and Journalology in AJRCCM 2002
Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 345 - 355.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
E. A. Renzoni, D. A. Walsh, M. Salmon, A. U. Wells, P. Sestini, A. G. Nicholson, S. Veeraraghavan, A. E. Bishop, H. M. Romanska, P. Pantelidis, et al.
Interstitial Vascularity in Fibrosing Alveolitis
Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 438 - 443.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
T. E. King Jr.
Nonspecific Interstitial Pneumonia and Systemic Sclerosis
Am. J. Respir. Crit. Care Med., June 15, 2002; 165(12): 1578 - 1579.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2002 American Thoracic Society